[1]Campisi G, Panzarella V, Matranga D, et al.Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic[J].Arch Oral Biol, 2008, 53(4):388-397[2]Soysa NS, Samaranayake LP, Ellepola AN.Diabetes mellitus as a contributory factor in oral candidosis[J].Diabet Med, 2006, 23(5):455-459[3]Weerasuriya N, Snape J.Oesophageal candidiasis in elderly patients risk factors,prevention and management[J].Drugs Aging, 2008, 25(2):119-130[4]Soysa NS, Samaranayake LP, Ellepola AN.Antimicrobials as a contributory factor in oral candidosis--a brief overview[J].Oral Dis, 2008, 14(2):138-143[5]Samaranayake YH, Samaranayake LP.Experimental oral candidiasis in animalmodels[J].Clin Microbiol Rev, 2001, 14(2):398-429[6]Junqueira JC, Vilela SF, Rossoni RD, et al.Oral colonization by yeasts in HIV-positive patientsin Brazil[J].Rev Inst Med Trop Sao Paulo, 2012, 54(1):17-24[7]Badiee P, Alborzi A, Davarpanah MA, etal.Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients[J].Arch Iran Med, 2010, 13(4):282-287[8]卫彦, 陆慧君, 张新成, 等.白念珠菌对唑类抗真菌药物耐药机制的研究进展[J].口腔医学, 2005, 25(5):311-313[9] Costa AC, Pereira CA, Junqueira JC, etal.Recent mouse and rat methods for the study of experimental oral candidiasis[J]. Virulence, 2013, 4:(5) 391-399.[10]沈佳娜, 张钰, 黄韧,等.小鼠念珠菌感染模型和抗感染免疫[J].中国实验动物学报, 2008, 16(3):233-237[11]Takakura N, Sato Y, Ishibashi H, et al.A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush[J].Microbiol Immunol, 2003, 47(5):321-326[12]Solis NV, Filler SG.Mouse model of oropharyngeal candidiasis[J].Nat Protoc, 2012, 7(4):637-642[13]Dangi YS, Soni ML, Namdeo KP.Oral candidiasis: A review[J].International Journal of Pharmacy & Pharmaceutical Sciences, 2010, 2(4):36-41[14]Bader T, Schr?ppel K, Bentink S, et al.Role of calcineurin in stress resistance,morphogenesis,and virulence of a Candida albicans wild-type strain[J].Infect Immun, 2006, 74(7):4366-4369[15]Wang L, Wang C, Mei H, et al.Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection[J].Mycopathologia, 2016, 181(1-2):29-39[16]Okada M, Hisajima T, Ishibashi H, et al.Pathological analysis of the Candida albicans-infected tongue tissues of a murine oral candidiasis model in the early infection stage[J].Arch Oral Biol, 2013, 58(4):444-450[17]罗银珠, 潘金春, 何丽芳, 等.白色念珠菌经口感染小鼠建立系统性感染模型[J].中国实验动物学报, 2016, 24(6):591-595[18] 杨连娟.IL-22和TNF-α在口腔粘膜抗白念珠菌感染固有免疫中的协同作用[D].上海第二军医大学,2013.[19]de Campos Rasteiro VM, da Costa AC, Araujo CF, et al.Essential oil of Melaleuca alternifolia for the treatment of oral candidiasis induced in an immunosuppressed mouse model[J].BMC Complement Altern Med, 2014, 14(1):1-10[20] Freire F, Ferraresi C, Jorge AO, et al.Photodynamic therapy of oral Candida infection in a mouse model. [J].J Photochem Photobiol B. 2016, 159: 161-168.[21]Hisajima T, Maruyama N, Tanabe Y, et al.Protective effects of farnesol againstoral candidiasis in mice[J].Microbiol Immunol, 2008, 52(7):327-333[22]Junqueira JC.Models hosts for the study of oral candidiasis[J].Adv Exp Med Biol, 2012, 7(10):95-105 |